Halestrap AP, Doran E, Gillespie JP, OToole A
Semaglutide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with Multiple Endocrine Neoplasia syndrome type 2
However, on October 7, 2024, the Outsourcing Facilities Association ( OFA ) filed suit against FDA in federal court in Fort Worth, alleging that FDAs decision to remove tirzepatide from the shortage list violated the Administrative Procedure Act (APA) because, inter alia , FDA failed to provide notice and seek comments from affected stakeholders
The article says most compounded semaglutide injections carry a 30-day beyond-use date when refrigerated, a much shorter window than the mass-manufactured products it contrasts them with
Membership lets you see your data right in each article and also gives you access to the members only information in the Lifehacks sections